Login / Signup
Mani Dastgheib
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 4
Top Topics
Placebo Controlled
Top Venues
Journal of cosmetic dermatology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Mani Dastgheib
,
Sama Heidari
,
Arghavan Azizpour
,
Mohammadreza Kavyani
,
Vahide Lajevardi
,
Amir Hooshang Ehsani
,
Amir Teimourpour
,
Maryam Danespazhooh
,
Mansour Nassiri Kashani
,
Kamran Balighi
Investigating the impact of added Profhilo mesogel to subcision versus subcision monotherapy in treating acne scars; a single-blinded, split-face randomized trial.
Journal of cosmetic dermatology
23 (6) (2024)
Mani Dastgheib
,
Sama Heidari
,
Arghavan Azizpour
,
Mohammadreza Kavyani
,
Vahide Lajevardi
,
Amir Hooshang Ehsani
,
Amir Teimourpour
,
Maryam Danespazhooh
,
Mansour Nassiri Kashani
,
Kamran Balighi
Investigating the impact of added Profhilo mesogel to subcision versus subcision monotherapy in treating acne scars; a single-blinded, split-face randomized trial.
Journal of cosmetic dermatology
23 (6) (2024)
Mani Dastgheib
,
Sama Heidari
,
Arghavan Azizpour
,
Mohammadreza Kavyani
,
Vahide Lajevardi
,
Amir Hooshang Ehsani
,
Amir Teimourpour
,
Maryam Danespazhooh
,
Mansour Nassiri Kashani
,
Kamran Balighi
Investigating the impact of added Profhilo mesogel to subcision versus subcision monotherapy in treating acne scars; a single-blinded, split-face randomized trial.
Journal of cosmetic dermatology
(2024)
Mani Dastgheib
,
Sama Heidari
,
Arghavan Azizpour
,
Mohammadreza Kavyani
,
Vahide Lajevardi
,
Amir Hooshang Ehsani
,
Amir Teimourpour
,
Maryam Danespazhooh
,
Mansour Nassiri Kashani
,
Kamran Balighi
Investigating the impact of added Profhilo mesogel to subcision versus subcision monotherapy in treating acne scars; a single-blinded, split-face randomized trial.
Journal of cosmetic dermatology
23 (6) (2024)